Editing Suxamethonium chloride (section)

==History==
Suxamethonium was first discovered in 1906 by [[Reid Hunt]] and René de M. Taveau.<ref>{{cite journal | vauthors = Hunt R, ((De M Taveau R)) |title=On the physiological action of certain cholin derivatives and new methods for detecting cholin |journal=The British Medical Journal |date=22 December 1906 |pages=1788-1791 |url=https://babel.hathitrust.org/cgi/pt?id=uiuo.ark:/13960/t5n94tj8n&seq=1850}}</ref> When studying the drug, animals were given [[curare]] and thus they missed the neuromuscular blocking properties of suxamethonium. Instead in 1949 an Italian group led by [[Daniel Bovet]] was first to describe succinylcholine induced paralysis. The clinical introduction of suxamethonium was described in 1951 by several groups. Papers published by Stephen Thesleff and Otto von Dardel in Sweden are important but also to be mentioned is work by Bruck, Mayrhofer and Hassfurther in Austria, Scurr and Bourne in UK, and Foldes in America.<ref name="pmid7047939">{{cite journal | vauthors = Dorkins HR | title = Suxamethonium-the development of a modern drug from 1906 to the present day | journal = Medical History | volume = 26 | issue = 2 | pages = 145–168 | date = April 1982 | pmid = 7047939 | pmc = 1139149 | doi = 10.1017/S0025727300041132 }}</ref>